January 15, 2021January 13, 2021
New Year, Same Old COVID-19 Fears

For me, the scariest part of the pandemic has been imagining one of my loved ones developing a severe case of COVID-19. Relatable statement, ... Read more
January 15, 2021January 15, 2021
United Therapeutics Sponsors PFF Registry

The Pulmonary Fibrosis Foundation (PFF) announced that United Therapeutics will sponsor the PFF Registry. The Registry is a research resource that tracks clinical data, ... Read more
January 14, 2021January 12, 2021
PTSD Is Common in Chronically Ill Patients. Here’s How I Address It

As a columnist for BioNews, I try to write about a variety of topics pertaining to patients living with idiopathic pulmonary fibrosis (IPF), ... Read more
January 13, 2021January 8, 2021
Transplant in the Time of Coronavirus

On a beautiful Thursday afternoon late last May, my partner and I took the dogs swimming at our secret spot at a nearby reservoir. ... Read more
January 13, 2021January 13, 2021
Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

Fatigue can be a significant burden for people with idiopathic pulmonary fibrosis (IPF), and tends to worsen as the disease progresses or, at ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

April 27, 2018April 27, 2018

Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests

News

Treatment with plant-derived aloperine reduces the severity of lung injury in a mouse model of pulmonary fibrosis, a new Chinese study reports. The research, “Aloperine Protects Mice against Bleomycin-induced Pulmonary Fibrosis by Attenuating Fibroblast Proliferation and Differentiation,” was published ... Read more

New Year, Same Old COVID-19 Fears

PTSD Is Common in Chronically Ill Patients. Here’s How I Address It

Transplant in the Time of Coronavirus

Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

First Patient Enrolls in Study of NAC for Targeted Treatment in IPF

Endeavor Raises $62M for New Trials for Taladegib IPF Therapy

These Resources Can Help Reduce Anxiety During the Pandemic

Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF

Subscribe to our mailing list

Top 10 Pulmonary Fibrosis Stories of 2020

$2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF

IPF Patient, Three Lakes Foundation Join to Bring ‘Second Wind’ to Others

OSIC Announces Winners of Pulmonary Fibrosis Progression Challenge

Focusing on What Is Still Possible This Holiday Season

Hello, I’m the Emotional Support Daughter

Diabetes Raises Risk of Lung Scarring Due to Ozone Pollution, Study Suggests

US Patent Issued for iBio’s Method of Boosting Anti-fibrotic Endostatin-derived Peptides

Moving On: A Room-by-Room Remembrance Ritual

Treprostinil Earns FDA Orphan Drug Designation for Treating IPF

Reflecting on Life’s Lessons During Another Special Birthday

UK Survey Highlights ‘Unrelenting’ COVID-19 Impact on PF Community

Winners of 2020 Innovation Challenge for PF Announced

GLPG1205 Safely Eases Lung Function Decline in IPF Patients, Phase 2 Trial Shows

Phase 3 INOpulse Trial Enrolls First Patient at Risk of PF-associated PH

NORD Push for Rare Disease Advisory Councils Focus of Dec. 16 Public Meeting

Queen Latifah, Bernie Williams Join in ILD Film ‘Beyond Breathless’

PF Clinical Researcher Receives NIH Award for Career Development

New Mouse Study Will Investigate EmtinB as Post-COVID Fibrosis Treatment

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

Potential IPF Treatment, LYT-100, Shows Good Tolerability in Trial

‘Second Wind’ Short Film Brings PF, Organ Donation Into Sharp Focus

1st Patient Enrolled in Trial Testing Ofev on Post-COVID-19 PF

Aloperine May Protect Against Pulmonary Fibrosis in Mouse Model, Study Suggests

New Year, Same Old COVID-19 Fears

United Therapeutics Sponsors PFF Registry

PTSD Is Common in Chronically Ill Patients. Here’s How I Address It

Transplant in the Time of Coronavirus

Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

Fatigue Weights on IPF Patients and Tends to Worsen Over Time, Study Finds

NORD Seeks Speakers for 2021 Virtual ‘Living Rare, Living Stronger’ Forum

First Patient Enrolls in Study of NAC for Targeted Treatment in IPF

Endeavor Raises $62M for New Trials for Taladegib IPF Therapy

These Resources Can Help Reduce Anxiety During the Pandemic

Dosing Begins in 2nd Phase 3 Trial of Antibody Treatment for IPF

Subscribe to our mailing list

Top 10 Pulmonary Fibrosis Stories of 2020

$2.4M NIH Grant Supports Boston Team Creating Cell Model for IPF

IPF Patient, Three Lakes Foundation Join to Bring ‘Second Wind’ to Others

OSIC Announces Winners of Pulmonary Fibrosis Progression Challenge

Focusing on What Is Still Possible This Holiday Season

Hello, I’m the Emotional Support Daughter

Diabetes Raises Risk of Lung Scarring Due to Ozone Pollution, Study Suggests

IPF Negatively Affects Patients’ Quality of Life, Review Study Finds

US Patent Issued for iBio’s Method of Boosting Anti-fibrotic Endostatin-derived Peptides

Moving On: A Room-by-Room Remembrance Ritual

Treprostinil Earns FDA Orphan Drug Designation for Treating IPF

Reflecting on Life’s Lessons During Another Special Birthday

UK Survey Highlights ‘Unrelenting’ COVID-19 Impact on PF Community

Winners of 2020 Innovation Challenge for PF Announced

GLPG1205 Safely Eases Lung Function Decline in IPF Patients, Phase 2 Trial Shows

Phase 3 INOpulse Trial Enrolls First Patient at Risk of PF-associated PH

There Is Power in Your Pulmonary Fibrosis Story

NORD Push for Rare Disease Advisory Councils Focus of Dec. 16 Public Meeting

Queen Latifah, Bernie Williams Join in ILD Film ‘Beyond Breathless’

PF Clinical Researcher Receives NIH Award for Career Development

New Mouse Study Will Investigate EmtinB as Post-COVID Fibrosis Treatment

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

Potential IPF Treatment, LYT-100, Shows Good Tolerability in Trial

‘Second Wind’ Short Film Brings PF, Organ Donation Into Sharp Focus

1st Patient Enrolled in Trial Testing Ofev on Post-COVID-19 PF